| UniProt ID | B4GN1_HUMAN | |
|---|---|---|
| UniProt AC | Q00973 | |
| Protein Name | Beta-1,4 N-acetylgalactosaminyltransferase 1 | |
| Gene Name | B4GALNT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 533 | |
| Subcellular Localization |
Golgi apparatus membrane Single-pass type II membrane protein. |
|
| Protein Description | Involved in the biosynthesis of gangliosides GM2, GD2 and GA2.. | |
| Protein Sequence | MWLGRRALCALVLLLACASLGLLYASTRDAPGLRLPLAPWAPPQSPRRPELPDLAPEPRYAHIPVRIKEQVVGLLAWNNCSCESSGGGLPLPFQKQVRAIDLTKAFDPAELRAASATREQEFQAFLSRSQSPADQLLIAPANSPLQYPLQGVEVQPLRSILVPGLSLQAASGQEVYQVNLTASLGTWDVAGEVTGVTLTGEGQADLTLVSPGLDQLNRQLQLVTYSSRSYQTNTADTVRFSTEGHEAAFTIRIRHPPNPRLYPPGSLPQGAQYNISALVTIATKTFLRYDRLRALITSIRRFYPTVTVVIADDSDKPERVSGPYVEHYLMPFGKGWFAGRNLAVSQVTTKYVLWVDDDFVFTARTRLERLVDVLERTPLDLVGGAVREISGFATTYRQLLSVEPGAPGLGNCLRQRRGFHHELVGFPGCVVTDGVVNFFLARTDKVREVGFDPRLSRVAHLEFFLDGLGSLRVGSCSDVVVDHASKLKLPWTSRDAGAETYARYRYPGSLDESQMAKHRLLFFKHRLQCMTSQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 79 | N-linked_Glycosylation | VGLLAWNNCSCESSG HEEEEECCCCCCCCC | 14.37 | UniProtKB CARBOHYD | |
| 104 | Ubiquitination | VRAIDLTKAFDPAEL EEEEECCCCCCHHHH | 55.12 | 21906983 | |
| 104 | Ubiquitination | VRAIDLTKAFDPAEL EEEEECCCCCCHHHH | 55.12 | 21906983 | |
| 179 | N-linked_Glycosylation | GQEVYQVNLTASLGT CCEEEEEEEEEEECC | 19.02 | UniProtKB CARBOHYD | |
| 224 | Phosphorylation | NRQLQLVTYSSRSYQ HHHHEEEEECCCCCC | 26.69 | 30576142 | |
| 250 | Phosphorylation | EGHEAAFTIRIRHPP CCCEEEEEEEECCCC | 12.48 | 24719451 | |
| 274 | N-linked_Glycosylation | LPQGAQYNISALVTI CCCCCCCCHHHHHHH | 15.06 | UniProtKB CARBOHYD | |
| 297 | Phosphorylation | DRLRALITSIRRFYP HHHHHHHHHHHHHCC | 20.96 | 22468782 | |
| 298 | Phosphorylation | RLRALITSIRRFYPT HHHHHHHHHHHHCCE | 13.70 | 22468782 | |
| 303 | Phosphorylation | ITSIRRFYPTVTVVI HHHHHHHCCEEEEEE | 9.00 | 25907765 | |
| 305 | Phosphorylation | SIRRFYPTVTVVIAD HHHHHCCEEEEEEEC | 19.89 | 25907765 | |
| 307 | Phosphorylation | RRFYPTVTVVIADDS HHHCCEEEEEEECCC | 16.13 | 25907765 | |
| 314 | Phosphorylation | TVVIADDSDKPERVS EEEEECCCCCCCCCC | 48.35 | 25907765 | |
| 377 | Phosphorylation | LVDVLERTPLDLVGG HHHHHHHCCHHHHHH | 20.87 | - | |
| 470 | Phosphorylation | FFLDGLGSLRVGSCS HHHHCCCCCCCCCCC | 20.32 | 24719451 | |
| 501 | Phosphorylation | RDAGAETYARYRYPG CCCCCCEEEECCCCC | 4.79 | - | |
| 517 | "N6,N6-dimethyllysine" | LDESQMAKHRLLFFK CCHHHHHHHHHHHHH | 24.74 | - | |
| 517 | Methylation | LDESQMAKHRLLFFK CCHHHHHHHHHHHHH | 24.74 | - | |
| 524 | "N6,N6-dimethyllysine" | KHRLLFFKHRLQCMT HHHHHHHHHHHHHHC | 22.08 | - | |
| 524 | Methylation | KHRLLFFKHRLQCMT HHHHHHHHHHHHHHC | 22.08 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of B4GN1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of B4GN1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of B4GN1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| B4GN1_HUMAN | B4GALNT1 | physical | 11018043 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 609195 | Spastic paraplegia 26, autosomal recessive (SPG26) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...